The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Allelic dosage of RB1 drives CDK4/6 inhibitor treatment resistance in metastatic breast cancer.
 
Anton Mikhailovich Safonov
No Relationships to Disclose
 
Chaitanya Bandlamudi
No Relationships to Disclose
 
Pier Selenica
No Relationships to Disclose
 
Antonio Marra
No Relationships to Disclose
 
Emanuela Ferraro
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
David B. Solit
Stock and Other Ownership Interests - Fore Biotherapeutics; Scorpion Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - BridgeBio Pharma; Lilly; Pfizer; Scorpion Therapeutics; Syros Pharmaceuticals; Vividion Therapeutics
 
Michael F. Berger
Consulting or Advisory Role - Lilly; PetDx
Research Funding - Grail
Patents, Royalties, Other Intellectual Property - Provisional patent pending for "Systems and Methods for Detecting Cancer via cfDNA Screening"
 
Larry Norton
Stock and Other Ownership Interests - Codagenix; Martell diagnostic; Medaptive Health; Samus Therapeutics
Honoraria - Agenus; ASCO; Codagenix; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Context Therapeutics; Oncology Pioneers; Prime Oncology; Sarah Lawrence College; Sarah Lawrence College; Sermonix Pharmaceuticals
Consulting or Advisory Role - Agenus; ASCO; Breast Cancer Research Program; Codagenix; Cold Spring Harbor Laboratory; Context Therapeutics; Hackensack University Medical Center; Martell diagnostic; Medaptive Health; Oncology Pioneers; Prime Oncology; Sarah Lawrence College; Sermonix Pharmaceuticals
Travel, Accommodations, Expenses - AACR; Breast Cancer Research Foundation; Breast Cancer Research Program; Cold Spring Harbor Laboratory; Oncology Pioneers
 
Simon N. Powell
Consulting or Advisory Role - Philips Healthcare; Varian Medical Systems
Research Funding - Philips Healthcare
 
Ronglai Shen
No Relationships to Disclose
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - AstraZeneca (Inst); Merck (Inst); Pfizer (Inst)
Other Relationship - Clinical Care Options; Clinical Education Alliance; MyMedEd; Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Artios; Daiichi Sankyo; Epic Sciences; Merck; Pfizer; Tempus; Zenith Pharmaceuticals
 
Sarat Chandarlapaty
Stock and Other Ownership Interests - Totus Medicines
Consulting or Advisory Role - AstraZeneca/MedImmune; Inivata; Lilly; Novartis; Paige.ai; Sanofi
Research Funding - AstraZeneca (Inst); Daiichi Sankyo (Inst); Lilly (Inst); Novartis (Inst); Paige.ai (Inst); Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent pending for (1) targeting mutant ER with ER PROTACS and (2) targeting CDK4/6 with CDK4/6 PROTACS (Inst)
Travel, Accommodations, Expenses - Novartis Institutes for BioMedical Research
Other Relationship - Peerview; Targeted Oncology; WebMD
(OPTIONAL) Uncompensated Relationships - Totus Medicines
 
Jorge S. Reis-Filho
Leadership - Grupo Oncoclinicas
Stock and Other Ownership Interests - PAIGE.AI; Repare Therapeutics
Consulting or Advisory Role - Genentech/Roche; Goldman Sachs; Invicro; Lilly; Novartis; Paige.AI; Personalis; Repare Therapeutics; Ventana Medical Systems; Volition RX
 
Pedram Razavi
Honoraria - Daiichi Sankyo/Lilly; Epic Sciences; Guardant Health; Inivata; Pfizer
Consulting or Advisory Role - AstraZeneca; bioTheranostics; Epic Sciences; Foundation Medicine; Guardant Health; Inivata; Natera; Novartis; Tempus
Research Funding - Archer (Inst); AstraZeneca (Inst); Epic Sciences (Inst); GRAIL (Inst); Guardant Health (Inst); Illumina (Inst); Novartis (Inst); Tempus (Inst)